Biography of Igor Matushansky
Last update: February 26, 2024Career
Igor was Global Head of Translational Development, Oncology at Daiichi Sankyo, and Global Head for Clinical and Scientific Development in the Gene & Cell Therapy Unit at Novartis. Igor Matushansky joined Crescendo Biologics in 2023.
Igor Matushansky is currently- Chief Medical Officer at Sail Biomedicines - View - Sail Biomedicines org chart
- Director at Crescendo Biologics - View - Crescendo Biologics org chart
Create your alert
to follow the career of Igor Matushansky.
Education
Igor Matushansky has a Bachelor of Arts from Columbia University in 1994 and a Doctor of Medicine from Albert Einstein College of Medicine in 2001.
They have also studied at Columbia University :
Find more alumni from Columbia University
More about Igor Matushansky
Selected links
Do you need to know more about Igor Matushansky? More results.
Participate
Social media
- Igor Matushansky on Google News, Twitter, LinkedIn, YouTube
- View the pictures of Igor Matushansky
The colleagues of Igor Matushansky
Company Colleagues
- At Sail Biomedicines, Igor Matushansky has 23 colleagues including Guillaume Pfefer (CEO & Director), Paula Hammond (Director)…
- At Crescendo Biologics, Igor Matushansky has 15 colleagues including Theodora Harold (CEO & Director), Kevin Johnson (Chairman of the Board)…
Industry Colleagues
- In the Biotechnology industry, Igor Matushansky has 30,259 colleagues in 2,283 companies located in 40 countries. 14,408 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Igor Matushansky.
Get in Touch
and ask for Igor Matushansky.
